PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 268 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $728,957 | -27.5% | 23,760 | -5.3% | 0.01% | -25.0% |
| Q2 2023 | $1,005,837 | -7.6% | 25,102 | -5.9% | 0.01% | -14.3% |
| Q1 2023 | $1,088,811 | -53.1% | 26,680 | -55.6% | 0.01% | -6.7% |
| Q4 2022 | $2,320,848 | +17.7% | 60,110 | +62.2% | 0.02% | -46.4% |
| Q3 2022 | $1,971,000 | -9.5% | 37,050 | -0.8% | 0.03% | -3.4% |
| Q2 2022 | $2,178,000 | -30.0% | 37,359 | -8.4% | 0.03% | -14.7% |
| Q1 2022 | $3,111,000 | +29.6% | 40,769 | +2.2% | 0.03% | +36.0% |
| Q4 2021 | $2,401,000 | – | 39,904 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |